Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Tadalafil Gummy vs Tablet in Healthy Volunteers
NCT04762082Phase 1Not yet recruiting
- Sponsor
- Seattle Gummy Company
- Start
- May 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of tadalafil in erectile dysfunction (ED) (5 arms), sponsored by Seattle Gummy Company. Primary endpoints: Maximum Plasma Concentration at 96 hours and Area Under the Plasma Drug Concentration Versus Time Curve at 96 hours. Planned start May 2025; status: not yet recruiting.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT04762082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04762082.